Q32 Bio Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Q32 Bio Inc. and other ETFs, options, and stocks.About QTTB
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives.
CEOJodie P. Morrison
CEOJodie P. Morrison
Employees42
Employees42
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2017
Founded2017
Employees42
Employees42
QTTB Key Statistics
Market cap44.31M
Market cap44.31M
Price-Earnings ratio-1.04
Price-Earnings ratio-1.04
Dividend yield—
Dividend yield—
Average volume150.63K
Average volume150.63K
High today$3.73
High today$3.73
Low today$3.48
Low today$3.48
Open price$3.63
Open price$3.63
Volume145.58K
Volume145.58K
52 Week high$6.37
52 Week high$6.37
52 Week low$1.35
52 Week low$1.35
Stock Snapshot
As of today, Q32 Bio Inc.(QTTB) shares are valued at $3.58. The company's market cap stands at 44.31M, with a P/E ratio of -1.04.
During the trading session on 2026-01-11, Q32 Bio Inc.(QTTB) shares reached a daily high of $3.73 and a low of $3.48. At a current price of $3.58, the stock is +2.9% higher than the low and still -4.0% under the high.
Trading activity shows a volume of 145.58K, compared to an average daily volume of 150.63K.
The stock's 52-week range extends from a low of $1.35 to a high of $6.37.
The stock's 52-week range extends from a low of $1.35 to a high of $6.37.
People also own
Based on the portfolios of people who own QTTB. This list is generated using Robinhood data, and it’s not a recommendation.